Evidence map›Paper›PMID 26862851›Full record

ArticleOncotarget2016

Brachyury identifies a class of enteroendocrine cells in normal human intestinal crypts and colorectal cancer.

Jana Jezkova, Jason S Williams, Filipe Pinto, Stephen J Sammut, Geraint T Williams, Simon Gollins, Ramsay J McFarlane, Rui Manuel Reis, Jane A Wakeman

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Immunology of Lynch Syndrome.Current oncology reports · 2021
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Jana JezkovaNorth West Cancer Research Institute, School of Medical Sciences, Bangor University, Bangor, UK.
Jason S WilliamsNorth West Cancer Research Institute, School of Medical Sciences, Bangor University, Bangor, UK.
Filipe PintoLife and Health Sciences Research Institute (ICVS), School Health Sciences, University Minho, Braga, Portugal.
Stephen J SammutNorth West Cancer Research Institute, School of Medical Sciences, Bangor University, Bangor, UK.
Geraint T WilliamsInstitute of Cancer and Genetics, Cardiff University Medical School, Cardiff, UK.
Simon GollinsNorth Wales Cancer Treatment Centre, Betsi Cadwaladr University Health Board, Bodelwyddan, UK.
Ramsay J McFarlaneNorth West Cancer Research Institute, School of Medical Sciences, Bangor University, Bangor, UK.
Rui Manuel ReisLife and Health Sciences Research Institute (ICVS), School Health Sciences, University Minho, Braga, Portugal.
Jane A WakemanNorth West Cancer Research Institute, School of Medical Sciences, Bangor University, Bangor, UK.
Bangor University · GBBetsi Cadwaladr University Health Board · GBCardiff University · GBHospital de Câncer de Barretos · BRUniversity of Minho · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Normal homeostasis of adult intestinal epithelium and repair following tissue damage is maintained by a balance of stem and differentiated cells, many of which are still only poorly characterised. Enteroendocrine cells of the gut are a small population of differentiated, secretory cells that are critical for integrating nutrient sensing with metabolic responses, dispersed amongst other epithelial cells. Recent evidence suggests that sub-sets of secretory enteroendocrine cells can act as reserve stem cells. Given the link between cells with stem-like properties and cancer, it is important that we identify factors that might provide a bridge between the two. Here, we identify a sub-set of chromogranin A-positive enteroendocrine cells that are positive for the developmental and cancer-associated transcription factor Brachyury in normal human small intestinal and colonic crypts. Whilst chromogranin A-positive enteroendocrine cells are also Brachyury-positive in colorectal tumours, expression of Brachyury becomes more diffuse in these samples, suggesting a more widespread function in cancer. The finding of the developmental transcription factor Brachyury in normal adult human intestinal crypts may extend the functional complexity of enteroendocrine cells and serves as a platform for assessment of the molecular processes of intestinal homeostasis that underpins our understanding of human health, cancer and aging.

Indexed as

Brachyury ProteinCell DifferentiationColorectal NeoplasmsEnteroendocrine CellsFetal ProteinsHumansIntestinal MucosaT-Box Domain ProteinsBrachyury ProteinFetal ProteinsT-Box Domain ProteinsBrachyurycolorectal cancercryptsenteroendocrine cellssmall intestine/colon

Identifiers

PMID26862851
PMCPMC4905487
OpenAlexW2301478824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.